JP5827407B2 - 4−[5−(ピリジン−4−イル)−1h−1,2,4−トリアゾール−3−イル]ピリジン−2−カルボニトリルの製造方法および中間体 - Google Patents
4−[5−(ピリジン−4−イル)−1h−1,2,4−トリアゾール−3−イル]ピリジン−2−カルボニトリルの製造方法および中間体 Download PDFInfo
- Publication number
- JP5827407B2 JP5827407B2 JP2014526957A JP2014526957A JP5827407B2 JP 5827407 B2 JP5827407 B2 JP 5827407B2 JP 2014526957 A JP2014526957 A JP 2014526957A JP 2014526957 A JP2014526957 A JP 2014526957A JP 5827407 B2 JP5827407 B2 JP 5827407B2
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- compound
- following formula
- pyridine
- pyridin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- UBVZQGOVTLIHLH-UHFFFAOYSA-N 4-[5-pyridin-4-yl-1h-[1,2,4]triazol-3-yl]-pyridine-2-carbonitrile Chemical compound C1=NC(C#N)=CC(C=2N=C(NN=2)C=2C=CN=CC=2)=C1 UBVZQGOVTLIHLH-UHFFFAOYSA-N 0.000 title claims description 16
- 238000000034 method Methods 0.000 title description 13
- 150000001875 compounds Chemical class 0.000 claims description 32
- -1 alkali metal alkoxide Chemical class 0.000 claims description 13
- UVTQPXJSXOYROI-UHFFFAOYSA-N N-[[amino-(2-cyanopyridin-4-yl)methylidene]amino]pyridine-4-carboxamide Chemical compound C(#N)C1=NC=CC(=C1)C(=N)NNC(=O)C1=CC=NC=C1 UVTQPXJSXOYROI-UHFFFAOYSA-N 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 229910052783 alkali metal Inorganic materials 0.000 claims description 10
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 239000003377 acid catalyst Substances 0.000 claims description 4
- 238000007333 cyanation reaction Methods 0.000 claims description 4
- 238000007363 ring formation reaction Methods 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 description 21
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 12
- QNCSFBSIWVBTHE-UHFFFAOYSA-N 1-oxidopyridin-1-ium-4-carbonitrile Chemical compound [O-][N+]1=CC=C(C#N)C=C1 QNCSFBSIWVBTHE-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 125000004093 cyano group Chemical group *C#N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- YIIMEMSDCNDGTB-UHFFFAOYSA-N Dimethylcarbamoyl chloride Chemical compound CN(C)C(Cl)=O YIIMEMSDCNDGTB-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 108010093894 Xanthine oxidase Proteins 0.000 description 2
- 102100033220 Xanthine oxidase Human genes 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- GPHQHTOMRSGBNZ-UHFFFAOYSA-N pyridine-4-carbonitrile Chemical compound N#CC1=CC=NC=C1 GPHQHTOMRSGBNZ-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 150000003852 triazoles Chemical group 0.000 description 2
- LEIMLDGFXIOXMT-UHFFFAOYSA-N trimethylsilyl cyanide Chemical compound C[Si](C)(C)C#N LEIMLDGFXIOXMT-UHFFFAOYSA-N 0.000 description 2
- GTLDTDOJJJZVBW-UHFFFAOYSA-N zinc cyanide Chemical compound [Zn+2].N#[C-].N#[C-] GTLDTDOJJJZVBW-UHFFFAOYSA-N 0.000 description 2
- BZFGKBQHQJVAHS-UHFFFAOYSA-N 2-(trifluoromethyl)pyridine-4-carboxylic acid Chemical compound OC(=O)C1=CC=NC(C(F)(F)F)=C1 BZFGKBQHQJVAHS-UHFFFAOYSA-N 0.000 description 1
- PPDYFTPCRSZNRD-UHFFFAOYSA-N 2-cyanopyridine-4-carbohydrazide Chemical class NNC(=O)C1=CC=NC(C#N)=C1 PPDYFTPCRSZNRD-UHFFFAOYSA-N 0.000 description 1
- OMPBCHVDILLLFU-UHFFFAOYSA-N 3-methyl-1-oxidopyridin-1-ium-4-carboxylic acid Chemical compound CC1=C[N+]([O-])=CC=C1C(O)=O OMPBCHVDILLLFU-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QCWTWMJMLSKQCJ-UHFFFAOYSA-N Isonicotinic acid N-oxide Chemical compound OC(=O)C1=CC=[N+]([O-])C=C1 QCWTWMJMLSKQCJ-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 0 O*(cc1)ccc1[Zn] Chemical compound O*(cc1)ccc1[Zn] 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- KTUQUZJOVNIKNZ-UHFFFAOYSA-N butan-1-ol;hydrate Chemical compound O.CCCCO KTUQUZJOVNIKNZ-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000021235 carbamoylation Effects 0.000 description 1
- 150000001805 chlorine compounds Chemical group 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000752 ionisation method Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Natural products OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- ORVHMLCJEKDDAX-UHFFFAOYSA-N methyl 2-cyanopyridine-4-carboxylate Chemical compound COC(=O)C1=CC=NC(C#N)=C1 ORVHMLCJEKDDAX-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- OWRABTHGOKNUDV-UHFFFAOYSA-N n,n-dipropylcarbamoyl chloride Chemical compound CCCN(C(Cl)=O)CCC OWRABTHGOKNUDV-UHFFFAOYSA-N 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/86—Hydrazides; Thio or imino analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Description
[1]下記式(4)
[2]下記式(2)
[3]下記式(2)
[4]下記式(4)
第一工程は、4−シアノピリジン−N−オキシド(2)と、イソニコチン酸ヒドラジドとを、アルカリ金属アルコキシドの存在下に反応させて化合物(3)を得る工程である。
用いられるアルカリ金属アルコキシドとしては、アルカリ金属C1−C6アルコキシドが好ましく、具体例としてナトリウムメチラート、ナトリウムエチラート等が挙げられる。この反応は、溶媒中で行うのが好ましく、溶媒としては、メタノール、エタノール等のアルコール系溶媒が好ましい。
第二工程は、化合物(3)をシアノ化剤によりシアノ化して化合物(4)を得る工程である。
第三工程は、化合物(4)を酸触媒下、閉環反応することにより化合物(1)を得る工程である。
1H−NMR:プロトン核磁気共鳴スペクトル、DMSO−d6:重水素ジメチルスルホキシド、Hz:ヘルツ、J:カップリング定数、s:シングレット、dd:ダブルダブレット、d:ダブレット、br:ブロード。尚、NMRは270MHz核磁気共鳴スペクトルを示し、内部標準物質としてTMS(テトラメチルシラン)を用いた。MSは質量分析を示し、イオン化法がESI(エレクトロスプレーイオン化法)である測定機器を用いた。
4−シアノピリジン−N−オキシド(2)5.00gをメタノール40mLに懸濁し、ナトリウムメチラート22.4mgを加え、窒素雰囲気下40℃で2時間攪拌した。同温にてイソニコチン酸ヒドラジド5.71gを加え40℃で4時間攪拌した。反応液を室温まで冷却した後、析出した結晶をろ取し、メタノール15mLで洗浄後、80℃で15時間乾燥し、N”−(4−ピリジンカルボニル)−4−ピリジンヒドラジドイミド−1−オキシド(3)9.60gを得た。
1H−NMR(DMSO−d6)δ(ppm):6.98(br,2H),7.81(d,2H,J=5.77Hz),7.85(d,2H,J=7.09Hz),8.29(d,2H,J=7.09Hz),8.73(d,2H,J=5.77Hz),10.37(br,1H)
MS m/z:256[M−H]-
N”−(4−ピリジンカルボニル)−4−ピリジンヒドラジドイミド−1−オキシド(3)10.0gをN,N−ジメチルホルムアミド48mLに懸濁し、窒素雰囲気下、40℃でジメチルカルバモイルクロリド9.20gを加え1時間撹拌した。同温にてシアン化ナトリウム2.48gを加え、さらに1時間撹拌した。反応液を5℃以下まで冷却した後、5%炭酸水素ナトリウム水溶液100mL、水100mLを順次滴下した。析出した結晶をろ取し、水100mLで洗浄した後、80℃で15時間減圧乾燥し、4−ピリジンカルボン酸N’−(2−シアノピリジン−4−カルボンイミドイル)ヒドラジド(4)9.28gを得た。
1H−NMR(DMSO−d6)δ(ppm):7.15(br,2H),7.82(d,2H,J=5.61Hz),8.14(d,1H,J=5.11Hz),8.37(s,1H),8.75(d,2H,J=5.61Hz),8.86(d,1H,J=5.11Hz),10.47(br,1H)
MS m/z:265[M−H]-
4−ピリジンカルボン酸N’−(2−シアノピリジン−4−カルボンイミドイル)ヒドラジド(4)9.25gに水82mL、2−ブタノール8.2mL、リン酸4.00gを加え、80℃で8時間撹拌した。反応液を室温まで冷却し、析出した結晶をろ取した後、水:2−ブタノール=10:1の混合溶液92.5mLで洗浄した。得られた結晶を80℃で13時間減圧乾燥し、4−[5−(ピリジン−4−イル)−1H−1,2,4−トリアゾール−3−イル]ピリジン−2−カルボニトリル(1)7.89gを得た。
1H−NMR(DMSO−d6)δ(ppm):8.02(dd,2H,J=4.59,1.62Hz),8.32(dd,1H,J=5.13,1.62Hz),8.55(dd,1H,J=1.62,1.08Hz),8.80(dd,2H,J=4.59,1.62Hz),8.93(dd,1H,5.13,1.08Hz)
MS m/z:247[M−H]-
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014526957A JP5827407B2 (ja) | 2012-07-25 | 2013-07-24 | 4−[5−(ピリジン−4−イル)−1h−1,2,4−トリアゾール−3−イル]ピリジン−2−カルボニトリルの製造方法および中間体 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012177538 | 2012-07-25 | ||
JP2012177538 | 2012-07-25 | ||
JP2014526957A JP5827407B2 (ja) | 2012-07-25 | 2013-07-24 | 4−[5−(ピリジン−4−イル)−1h−1,2,4−トリアゾール−3−イル]ピリジン−2−カルボニトリルの製造方法および中間体 |
PCT/JP2013/070005 WO2014017516A1 (ja) | 2012-07-25 | 2013-07-24 | 4-[5-(ピリジン-4-イル)-1h-1,2,4-トリアゾール-3-イル]ピリジン-2-カルボニトリルの製造方法および中間体 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP5827407B2 true JP5827407B2 (ja) | 2015-12-02 |
JPWO2014017516A1 JPWO2014017516A1 (ja) | 2016-07-11 |
Family
ID=49997325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014526957A Active JP5827407B2 (ja) | 2012-07-25 | 2013-07-24 | 4−[5−(ピリジン−4−イル)−1h−1,2,4−トリアゾール−3−イル]ピリジン−2−カルボニトリルの製造方法および中間体 |
Country Status (19)
Country | Link |
---|---|
US (1) | US9428488B2 (ja) |
EP (1) | EP2878595A4 (ja) |
JP (1) | JP5827407B2 (ja) |
KR (1) | KR101719891B1 (ja) |
CN (1) | CN104411686B (ja) |
AU (1) | AU2013293974B2 (ja) |
BR (1) | BR112014032229B1 (ja) |
CA (1) | CA2876268C (ja) |
HK (1) | HK1204788A1 (ja) |
IL (1) | IL236081A (ja) |
IN (1) | IN2014DN10530A (ja) |
MX (1) | MX362102B (ja) |
MY (1) | MY185203A (ja) |
NZ (1) | NZ702797A (ja) |
PH (1) | PH12015500160B1 (ja) |
RU (1) | RU2644766C2 (ja) |
TW (1) | TWI580675B (ja) |
WO (1) | WO2014017516A1 (ja) |
ZA (1) | ZA201500462B (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105367490B (zh) * | 2014-08-18 | 2019-01-04 | 上海医药工业研究院 | 合成托吡司他的新中间体及其制备方法 |
CN107531677A (zh) | 2015-02-25 | 2018-01-02 | 法尔玛赞公司 | 用于制备托匹司他及其中间体的方法 |
CN105693699B (zh) * | 2015-03-30 | 2019-06-18 | 苏州晶云药物科技股份有限公司 | 托吡司他的晶型及其制备方法 |
CN104758263B (zh) * | 2015-04-22 | 2017-08-22 | 青岛正大海尔制药有限公司 | 一种托匹司他片及其制备方法 |
CN105294656A (zh) * | 2015-10-10 | 2016-02-03 | 大道隆达(北京)医药科技发展有限公司 | 一种托匹司他的制备工艺和方法 |
CN106008465A (zh) * | 2016-03-16 | 2016-10-12 | 江苏悦兴药业有限公司 | 一种托匹司他杂质的合成方法 |
CN108101840A (zh) * | 2018-01-26 | 2018-06-01 | 南京华威医药科技集团有限公司 | 托吡司他及其中间体制备方法 |
CN113666909B (zh) * | 2020-05-14 | 2024-07-02 | 鲁南制药集团股份有限公司 | 一种托匹司他的制备方法 |
CN115093399A (zh) * | 2022-07-29 | 2022-09-23 | 武汉工程大学 | 一种抗痛风药物托匹司他的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61152661A (ja) * | 1984-12-21 | 1986-07-11 | チバ ― ガイギー アクチエンゲゼルシャフト | 1,2,4‐トリアゾール誘導体 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3947577A (en) * | 1973-05-21 | 1976-03-30 | Merck & Co., Inc. | Anti-hyperuricemia composition |
US4097599A (en) * | 1973-11-13 | 1978-06-27 | Commonwealth Scientific And Industrial Research Organization | Triazoles |
AR241530A1 (es) | 1984-12-21 | 1992-08-31 | Ciba Geigy A G Cesionaria De F | 1,2,4-triazoles, composicion para el control de pestes y procedimiento para la preparacion de 1,2,4-triazoles. |
JP3217846B2 (ja) * | 1992-03-04 | 2001-10-15 | クミアイ化学工業株式会社 | トリアゾール誘導体及び殺虫剤 |
PT1123287E (pt) * | 1998-10-23 | 2003-12-31 | Dow Agrosciences Llc | 1-(piridil substituido)-1,2,4-triazoles insecticidas |
JP2003064410A (ja) | 2001-08-22 | 2003-03-05 | Nippon Steel Corp | 転炉吹錬方法および上吹きランス |
CN1561340B (zh) | 2002-01-28 | 2012-05-23 | 株式会社富士药品 | 1,2,4-三唑类化合物 |
JP2005009991A (ja) | 2003-06-18 | 2005-01-13 | Alpine Electronics Inc | 車載用ナビゲーション装置及び車載用ナビゲーション装置の表示方法 |
WO2005009991A1 (ja) | 2003-07-24 | 2005-02-03 | Fujiyakuhin Co., Ltd. | 1,2,4−トリアゾール化合物の製造方法及びその中間体 |
JP2005041802A (ja) * | 2003-07-25 | 2005-02-17 | Fujiyakuhin Co Ltd | 1,2,4−トリアゾール化合物の製造方法 |
US20060189811A1 (en) | 2004-07-23 | 2006-08-24 | Fujiyakuhin Co., Ltd. | Process for producing 1,2,4-triazole compound and intermediate therefor |
-
2013
- 2013-07-24 CN CN201380035703.1A patent/CN104411686B/zh active Active
- 2013-07-24 US US14/406,637 patent/US9428488B2/en not_active Expired - Fee Related
- 2013-07-24 MY MYPI2014703681A patent/MY185203A/en unknown
- 2013-07-24 WO PCT/JP2013/070005 patent/WO2014017516A1/ja active Application Filing
- 2013-07-24 MX MX2015001114A patent/MX362102B/es active IP Right Grant
- 2013-07-24 IN IN10530DEN2014 patent/IN2014DN10530A/en unknown
- 2013-07-24 TW TW102126521A patent/TWI580675B/zh not_active IP Right Cessation
- 2013-07-24 JP JP2014526957A patent/JP5827407B2/ja active Active
- 2013-07-24 RU RU2015106138A patent/RU2644766C2/ru active
- 2013-07-24 KR KR1020147034604A patent/KR101719891B1/ko active IP Right Grant
- 2013-07-24 BR BR112014032229-5A patent/BR112014032229B1/pt not_active IP Right Cessation
- 2013-07-24 EP EP13822690.7A patent/EP2878595A4/en not_active Withdrawn
- 2013-07-24 CA CA2876268A patent/CA2876268C/en not_active Expired - Fee Related
- 2013-07-24 AU AU2013293974A patent/AU2013293974B2/en not_active Ceased
- 2013-07-24 NZ NZ702797A patent/NZ702797A/en not_active IP Right Cessation
-
2014
- 2014-12-04 IL IL236081A patent/IL236081A/en active IP Right Grant
-
2015
- 2015-01-22 ZA ZA2015/00462A patent/ZA201500462B/en unknown
- 2015-01-23 PH PH12015500160A patent/PH12015500160B1/en unknown
- 2015-06-05 HK HK15105377.5A patent/HK1204788A1/xx unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61152661A (ja) * | 1984-12-21 | 1986-07-11 | チバ ― ガイギー アクチエンゲゼルシャフト | 1,2,4‐トリアゾール誘導体 |
Non-Patent Citations (1)
Title |
---|
JPN6015032292; Bioorganic & Medicinal Chemistry Letters 19, 2009, pp.6225-6229 * |
Also Published As
Publication number | Publication date |
---|---|
IL236081A0 (en) | 2015-02-01 |
KR20150035586A (ko) | 2015-04-06 |
AU2013293974B2 (en) | 2017-06-01 |
MX362102B (es) | 2019-01-04 |
MX2015001114A (es) | 2015-04-08 |
AU2013293974A1 (en) | 2015-01-22 |
EP2878595A4 (en) | 2015-12-09 |
CA2876268A1 (en) | 2014-01-30 |
KR101719891B1 (ko) | 2017-03-24 |
WO2014017516A1 (ja) | 2014-01-30 |
CN104411686B (zh) | 2016-08-31 |
US9428488B2 (en) | 2016-08-30 |
BR112014032229A2 (pt) | 2017-06-27 |
IL236081A (en) | 2017-11-30 |
CN104411686A (zh) | 2015-03-11 |
TWI580675B (zh) | 2017-05-01 |
JPWO2014017516A1 (ja) | 2016-07-11 |
US20150166510A1 (en) | 2015-06-18 |
MY185203A (en) | 2021-04-30 |
HK1204788A1 (en) | 2015-12-04 |
IN2014DN10530A (ja) | 2015-08-21 |
RU2015106138A (ru) | 2016-09-10 |
EP2878595A1 (en) | 2015-06-03 |
ZA201500462B (en) | 2016-10-26 |
PH12015500160A1 (en) | 2015-03-16 |
TW201408642A (zh) | 2014-03-01 |
CA2876268C (en) | 2016-12-20 |
BR112014032229B1 (pt) | 2021-02-09 |
PH12015500160B1 (en) | 2015-03-16 |
NZ702797A (en) | 2017-03-31 |
RU2644766C2 (ru) | 2018-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5827407B2 (ja) | 4−[5−(ピリジン−4−イル)−1h−1,2,4−トリアゾール−3−イル]ピリジン−2−カルボニトリルの製造方法および中間体 | |
JP6108112B2 (ja) | 改良されたルフィナミド調製プロセス | |
TWI426074B (zh) | 5-(2-胺基-嘧啶-4-基)-2-芳基-1h-吡咯-3-羧醯胺之製造方法 | |
WO2016074532A1 (zh) | 艾立替尼的制备方法 | |
JP6190067B2 (ja) | フルオロフェニルピラゾール化合物 | |
JP7205529B2 (ja) | オキサゾリジノン化合物の製造方法 | |
JP2003500479A (ja) | カテコールヒドラゾン誘導体、製造方法及びこれを含む医薬組成物 | |
JP2005041802A (ja) | 1,2,4−トリアゾール化合物の製造方法 | |
KR100574350B1 (ko) | 2-아미노피리딘 유도체의 제조방법 | |
RU2330020C2 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ АМИНОПИРИДИНА В КАЧЕСТВЕ АНТАГОНИСТОВ mGIuR5 | |
JPH01156966A (ja) | リポキシゲナーゼ抑制作用を有するピリダジノン、トリアジノンおよびオキサピリダジノン化合物 | |
JP4879907B2 (ja) | フェニル2−ピリミジニルケトン類の製造方法及びその新規中間体 | |
CN109970654B (zh) | 一系列取代2-苯基吡唑衍生物及其制备方法和应用 | |
JPWO2018168899A1 (ja) | ベンズイミダゾール誘導体の製造方法 | |
WO1991001315A1 (en) | New quinoline derivatives and process for the preparation thereof | |
JPH10500421A (ja) | ベンゾピラン化合物の製造方法 | |
JPS5916878A (ja) | 2,4−ジヒドロキシ−3−アセチルキノリン類の製造方法 | |
JP2001158774A (ja) | 6−トリフルオロメチルニコチン酸類の製造方法 | |
CN105934431A (zh) | 取代脲类化合物的制备方法 | |
KR20040005897A (ko) | 테트라치환된 이미다졸 유도체의 제조방법 및 그의 신규한결정 구조 | |
JP2010105943A (ja) | 5−{4−[2−(5−エチル−2−ピリジル)エトキシ]ベンジル}−2,4−チアゾリジンジオン塩酸塩の製造方法 | |
JPS604182A (ja) | ピリミドン誘導体及びその製法 | |
JPH02138171A (ja) | ラクタム誘導体 | |
JPS60109553A (ja) | アミノカルボキサミドのアルフアーフエニルベンジリデン誘導体の新規な調製法および中間体 | |
JPH0348660A (ja) | 新規置換ピリジン誘導体及びその用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150901 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150929 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20151015 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5827407 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |